open access

Vol 50, No 1 (2019)
Case Report / Kazuistyka
Submitted: 2018-11-05
Published online: 2019-05-08
Get Citation

Abnormal hemostasis screening tests leading to diagnosis of multiple myeloma

Teresa Iwaniec1, Joanna Zdziarska2, Artur Jurczyszyn2
DOI: 10.2478/ahp-2019-0006
·
Acta Haematol Pol 2019;50(1):32-35.
Affiliations
  1. Division of Molecular Biology and Clinical Genetics, Department of Medicine, Jagiellonian University Medical College, Krakow, Poland
  2. Department of Haematology, Jagiellonian University Medical College, Krakow, Poland

open access

Vol 50, No 1 (2019)
Case Report / Kazuistyka
Submitted: 2018-11-05
Published online: 2019-05-08

Abstract

Multiple myeloma (MM) is a rare malignancy, characterized by clonal proliferation of plasma cells, secreting monoclonal immunoglobulin. It is usually diagnosed based on histopathologic and immunophenotypic bone marrow examination. Abnormal results of screening coagulation tests, including prothrombin time, activated partial thromboplastin time and thrombin time, are commonly encountered in patients with plasma cell neoplasms. They do not, however, reflect bleeding tendency. We describe a 71-year-old patient who was accidentally diagnosed with multiple myeloma during coagulation diagnostics.

Abstract

Multiple myeloma (MM) is a rare malignancy, characterized by clonal proliferation of plasma cells, secreting monoclonal immunoglobulin. It is usually diagnosed based on histopathologic and immunophenotypic bone marrow examination. Abnormal results of screening coagulation tests, including prothrombin time, activated partial thromboplastin time and thrombin time, are commonly encountered in patients with plasma cell neoplasms. They do not, however, reflect bleeding tendency. We describe a 71-year-old patient who was accidentally diagnosed with multiple myeloma during coagulation diagnostics.

Get Citation

Keywords

multiple myleoma; paraprotein; hemostasis screening test; thrombin time

About this article
Title

Abnormal hemostasis screening tests leading to diagnosis of multiple myeloma

Journal

Acta Haematologica Polonica

Issue

Vol 50, No 1 (2019)

Pages

32-35

Published online

2019-05-08

Page views

113

Article views/downloads

409

DOI

10.2478/ahp-2019-0006

Bibliographic record

Acta Haematol Pol 2019;50(1):32-35.

Keywords

multiple myleoma
paraprotein
hemostasis screening test
thrombin time

Authors

Teresa Iwaniec
Joanna Zdziarska
Artur Jurczyszyn

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl